BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 27007541)

  • 1. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
    Raszewski G; Chwedorowicz R; Chwedorowicz A; Gustaw Rothenberg K
    Ann Agric Environ Med; 2016; 23(1):193-6. PubMed ID: 27007541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of MTHFR C677T, serum vitamin levels and cognition in subjects with hyperhomocysteinemia in China.
    Cheng DM; Jiang YG; Huang CY; Kong HY; Pang W; Yang HP
    Nutr Neurosci; 2010 Aug; 13(4):175-82. PubMed ID: 20670473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease.
    Li L; Cao D; Desmond R; Rahman A; Lah JJ; Levey AI; Zamrini E
    Dement Geriatr Cogn Disord; 2008; 26(4):384-90. PubMed ID: 18931498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
    Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T
    Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Farina N; Jernerén F; Turner C; Hart K; Tabet N
    Exp Gerontol; 2017 Dec; 99():146-150. PubMed ID: 29024723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease?
    Seshadri S
    J Alzheimers Dis; 2006 Aug; 9(4):393-8. PubMed ID: 16917147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
    Jernerén F; Cederholm T; Refsum H; Smith AD; Turner C; Palmblad J; Eriksdotter M; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Freund-Levi Y
    J Alzheimers Dis; 2019; 69(1):189-197. PubMed ID: 30958356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia.
    Huang CW; Chang WN; Huang SH; Lui CC; Chen NC; Chang YT; Lee CC; Chang CC; Chang AY
    Eur J Neurol; 2013 Aug; 20(8):1191-7. PubMed ID: 23581395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients.
    Annerbo S; Wahlund LO; Lökk J
    Dement Geriatr Cogn Disord; 2005; 20(4):209-14. PubMed ID: 16088136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine, B Vitamins, and Cognitive Impairment.
    Smith AD; Refsum H
    Annu Rev Nutr; 2016 Jul; 36():211-39. PubMed ID: 27431367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease.
    Lepara O; Alajbegovic A; Zaciragic A; Nakas-Icindic E; Valjevac A; Lepara D; Hadzovic-Dzuvo A; Fajkic A; Kulo A; Sofic E
    J Neural Transm (Vienna); 2009 Dec; 116(12):1651-6. PubMed ID: 19809863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
    Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
    JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: a 10-year systematic review of randomised controlled trials.
    D'Cunha NM; Georgousopoulou EN; Dadigamuwage L; Kellett J; Panagiotakos DB; Thomas J; McKune AJ; Mellor DD; Naumovski N
    Br J Nutr; 2018 Feb; 119(3):280-298. PubMed ID: 29310724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of Vitamins and Homocysteine in Older Adults with Alzheimer Disease or Mild Cognitive Impairment in Cuba.
    Lanyau-Domínguez Y; Macías-Matos C; Jesús J; María G; Suárez-Medina R; Eugenia M; Noriega-Fernández L; Guerra-Hernández M; Calvo-Rodríguez M; Sánchez-Gil Y; García-Klibanski M; Herrera-Javier D; Arocha-Oriol C; Díaz-Domínguez M
    MEDICC Rev; 2020 Oct; 22(4):40-47. PubMed ID: 33295319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up.
    Huang CW; Chang WN; Lui CC; Chen CF; Lu CH; Wang YL; Chen C; Juang YY; Lin YT; Tu MC; Chang CC
    Curr Alzheimer Res; 2010 Sep; 7(6):527-33. PubMed ID: 20455861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.
    Ulstein I; Bøhmer T
    J Alzheimers Dis; 2017; 55(2):717-725. PubMed ID: 27716664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging.
    Mizrahi EH; Jacobsen DW; Debanne SM; Traore F; Lerner AJ; Friedland RP; Petot GJ
    J Nutr Health Aging; 2003; 7(3):160-5. PubMed ID: 12766793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
    Seshadri S; Beiser A; Selhub J; Jacques PF; Rosenberg IH; D'Agostino RB; Wilson PW; Wolf PA
    N Engl J Med; 2002 Feb; 346(7):476-83. PubMed ID: 11844848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.